lobbying_activities: 3241286

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
3241286	83e1e33f-fd76-4a12-a597-7bb69f32edd7	Q3	ENDGAME STRATEGIES, LLC	400579747	ASSOCIATION OF ACCESSIBLE MEDICINES	2024	third_quarter	CPT	PREVAIL Act, S.2220. Patent Eligibility Restoration Act, S. 2140. General opposition to legislative efforts to weaken the Patent Trial & Appeal Board at the USPTO.	SENATE	30000		0	0	2024-10-16T16:24:40-04:00